On March 11, the World Health Organization (WHO) declared the coronavirus disease 2019 (COVID-19) a pandemic.
COVID-19 is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Common symptoms include fever, cough, fatigue, shortness of breath, and loss of smell and taste. While the majority of cases result in mild symptoms, some progress to acute respiratory distress syndrome (ARDS) possibly precipitated by cytokine storm, multi-organ failure, septic shock, and blood clots.
The popularity of this disease comes from its rapid spread and, therefore, the quick ability to infect. Up to the date, this has led to over 11 million of cases confirmed by PCR and 530.000 fatalities worldwide. The imminent damage of the COVID-19 disease has put the world on hold. Thus, the urgent need for a vaccine that will protect us against the new coronavirus has emerged.
Candidate vaccines in clinical evaluation
There is an enormous global effort to develop vaccines for protection against COVID-19, and at least nineteen vaccine candidates have, as of early July 2020 entered clinical trials, including phase III trials. However, the EMA expects that it may take at least one year before a vaccine is approved and available for widespread use in the EU/EEA.
Being in the spotlight and having big pharmaceuticals companies such as GSK, AstraZeneca, or Pfizer putting their efforts on the development of a vaccine against SARS-CoV-2 requires good visualization of such scientific advances.
In 3DforScience, we are committed to the pharmaceutical and biotechnological industries. We are also devoted to supporting as much as we can to the visualization of the emerging treatments and vaccines to combat this pandemic. Thus, if your company is currently developing a vaccine, we want to help you visualize the Mechanism of Action (MoA) of your candidate vaccine and the value of it to ensure it reaches a huge target.
How can we visualize vaccine candidates?
The top solution to visualize your vaccine candidate is a 3D medical animation video explaining the Mechanism of Action (MoA) of it. Trough an animation video, the complex biological processes by which your drug candidate will exert their effect on our body against SARS-CoV-2 is explained in just a few seconds in a clear, concise, and engaging way.
In an animation video, you can show to the world the structure of the platform of your drug candidate, whether it is a NonReplicating Viral Vector, DNA, or RNA. Besides, it will show how such a platform acts within the body to elude an immunological response that will lead to antibody production.
The combination of high-detailed graphics, a voice-over, and onscreen text following compelling storytelling will ensure your advancements reach the biggest audience possible. In addition, this tool creates a strong branding reinforcement since all the elements create will follow your branding guidelines and corporate colors.
By creating an animation, you will get an enormous amount of material that later, will help you to promote your vaccine worldwide. It might be a loop of your platform, assets for interactive presentations that will help you to spread the benefits of your technologies, or even the creation of a threedimensional story using VR and AR technologies that will help the world immerse in your science.
Creating successful presentations with the highest quality graphics that will explain by themselves the benefits and the underlying science of your vaccine candidate, it is also crucial to differentiate yourself from the competitors and show the benefits and the advances of your vaccine.
It is also crucial you have enough material for your social media to ensure the entire world is aware of the advancements you are doing and spread hope in that a cure against this virus is not far away.
In 3DforScience, we want to help you visualize your advancements and spread awareness and hope to the world through scientific communication.
If you are looking for innovative and efficient approaches to visualize your vaccine candidates, contact us. Our team of experts in animation, artists, scientific communication, and scientists will help you adding value to your science.